Reaching and maintaining optimal glycemic control while avoiding both hypo- and hyperglycemia remains a daily challenge for people living with type 1 diabetes (T1D), despite advances in insulin therapy and glucose monitoring options [1]. The gene discussed is INS; the disease is type 1 diabetes mellitus.